Home - Products - Others - Other Targets - Brain Injury Derived Neurotrophic Peptide

Brain Injury Derived Neurotrophic Peptide

CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide( ——— )

Catalog No. M42153 CAS No. 148330-12-5

Brain Injury Derived Neurotrophic Peptide

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Brain Injury Derived Neurotrophic Peptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Brain Injury Derived Neurotrophic Peptide
  • Description
    Brain Injury Derived Neurotrophic Peptide
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    148330-12-5
  • Formula Weight
    1387.61
  • Molecular Formula
    C62H102N18O18
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • F16

    F16 inhibits the growth of neu-overexpressing cells and the proliferation of mammary epithelial.

  • Nitazoxanide

    Nitazoxanide, also known by the brand name Alinia, is a synthetic nitrothiazolyl-salicylamide derivative and an anti-protozoal agent.

  • Goserelin acetate

    Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.